Stanley R Riddell Selected Research

Minor Histocompatibility Antigens

3/2011	Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.
6/2010	Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.
5/2010	Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.
5/2009	HapMap scanning of novel human minor histocompatibility antigens.
8/2008	C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
5/2007	A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A2902 and -B4403.
12/2004	Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
1/2004	Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.
11/2003	Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling.
9/2003	The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stanley R Riddell Research Topics

Disease

88	Neoplasms (Cancer) 04/2024 - 08/2002
20	Leukemia 04/2024 - 03/2002
19	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 12/2002
14	Infections 01/2024 - 09/2002
11	Lymphoma (Lymphomas) 06/2023 - 09/2008
8	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 01/2004
6	Melanoma (Melanoma, Malignant) 01/2023 - 05/2005
6	Multiple Myeloma 01/2023 - 07/2011
5	Cytokine Release Syndrome 10/2023 - 11/2017
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 11/2010
4	Testicular Neoplasms (Testicular Cancer) 12/2020 - 07/2011
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023 - 01/2007
3	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 09/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 06/2010
3	Lymphopenia (Lymphocytopenia) 01/2022 - 01/2003
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2007
3	Synovial Sarcoma (Synovioma) 01/2021 - 01/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2019 - 08/2013
3	Inflammation (Inflammations) 01/2019 - 09/2002
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 01/2016
2	Measles 01/2022 - 11/2019
2	Neutropenia 01/2022 - 08/2013
2	Disease Progression 01/2021 - 09/2017
2	Myxoid Liposarcoma 01/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2010 - 09/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2008 - 12/2004
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Glioblastoma (Glioblastoma Multiforme) 10/2022
1	Chronic Disease (Chronic Diseases) 10/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

46	Chimeric Antigen ReceptorsIBA 04/2024 - 09/2008
43	AntigensIBA 02/2024 - 03/2002
13	Minor Histocompatibility AntigensIBA 03/2011 - 08/2002
11	CytokinesIBA 02/2024 - 04/2009
10	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 05/2005
7	CD19-specific chimeric antigen receptorIBA 11/2019 - 01/2016
6	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2004
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023 - 11/2019
5	LigandsIBA 10/2022 - 04/2003
5	EpitopesIBA 01/2022 - 07/2006
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2016
5	Peptides (Polypeptides)IBA 07/2011 - 05/2005
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 01/2014
4	Interleukin-2 (IL2)IBA 01/2023 - 09/2003
4	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2023 - 11/2019
4	fludarabineIBA 11/2017 - 12/2004
4	HLA Antigens (Human Leukocyte Antigens)IBA 04/2015 - 05/2003
3	RNA (Ribonucleic Acid)IBA 04/2024 - 10/2008
3	H antigenIBA 04/2024 - 08/2002
3	Monoclonal AntibodiesIBA 01/2024 - 11/2010
3	Interleukin-15 (Interleukin 15)IBA 01/2023 - 01/2021
3	B-Cell Maturation AntigenIBA 01/2023 - 11/2019
3	AntibodiesIBA 11/2022 - 06/2017
3	Immunoglobulin G (IgG)IBA 01/2022 - 11/2016
3	AutoantigensIBA 12/2020 - 08/2007
3	micaIBA 04/2009 - 04/2003
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 11/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 12/2015
2	InterferonsIBA 12/2020 - 01/2019
2	ibrutinibIBA 01/2020 - 09/2017
2	Epithelial Cell Adhesion MoleculeIBA 12/2019 - 01/2019
2	Cetuximab (Erbitux)FDA Link 11/2016 - 08/2011
2	Ganciclovir (Cytovene)FDA LinkGeneric 08/2013 - 10/2003
2	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 06/2013 - 11/2010
2	MHC class I-related chain AIBA 04/2009 - 04/2003
2	NK Cell Lectin-Like Receptor Subfamily KIBA 04/2009 - 04/2003
2	Thymidine KinaseIBA 03/2006 - 02/2003
2	DNA (Deoxyribonucleic Acid)IBA 04/2005 - 01/2003
1	Single-Chain AntibodiesIBA 02/2024
1	human ERBB2 proteinIBA 02/2024
1	Transaminases (Aminotransferases)IBA 01/2024
1	durvalumabIBA 10/2023
1	Toll-Like Receptor 4IBA 10/2023
1	NKTR-255IBA 01/2023
1	crenigacestatIBA 01/2023
1	SolutionsIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	Cell Surface ReceptorsIBA 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	ChemokinesIBA 01/2021
1	bempegaldesleukinIBA 12/2020

Therapy/Procedure

51	Therapeutics 04/2024 - 03/2002
26	Immunotherapy 04/2024 - 03/2002
13	Cell Transplantation 10/2022 - 12/2004
12	Drug Therapy (Chemotherapy) 10/2022 - 11/2009
10	Hematopoietic Stem Cell Transplantation 04/2024 - 03/2002
4	Transplantation 04/2013 - 01/2003
4	Stem Cell Transplantation 07/2011 - 01/2003
2	Radiotherapy 10/2023 - 12/2009
1	Immunomodulation 10/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Aftercare (After-Treatment) 12/2020